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Analysis of human heart mitochondrial DNA (mtDNA) by
electron microscopy and agarose gel electrophoresis revealed a
complete absence of the -type replication intermediates seen
abundantly inmtDNAfromall other tissues. InsteadonlyY- and
X-junctional forms were detected after restriction digestion.
Uncut heart mtDNA was organized in tangled complexes of up
to 20 or more genome equivalents, which could be resolved to
genomic monomers, dimers, and linear fragments by treatment
with the decatenating enzyme topoisomerase IV plus the cruci-
form-cutting T7 endonuclease I. Human and mouse brain also
contained a population of such mtDNA forms, which were
absent, however, from mouse, rabbit, or pig heart. Overexpres-
sion in transgenic mice of two proteins involved inmtDNA rep-
lication, namely humanmitochondrial transcription factor A or
themouseTwinkleDNAhelicase, generated abundant four-way
junctions in mtDNA of heart, brain, and skeletal muscle. The
organization of mtDNA of human heart as well as of mouse and
human brain in complex junctional networks replicating via a
presumed non- mechanism is unprecedented in mammals.
The structure and organization of mitochondrial DNA
(mtDNA)2 vary considerably in different organisms (1, 2). The
complexity and diversity of plant and fungal mitochondrial
genomes is contrasted by the apparent simplicity of mtDNA
organization in metazoans. mtDNA replication also differs
between taxa: in protists, fungi, and plants documented mech-
anisms include conventional  replication (3), rolling circle rep-
lication (4–6), and recombination-dependent replication (7,
8). Some mitochondrial plasmids also utilize reverse transcrip-
tion (9).
In animals, where the mitochondrial genome is generally a
compact circular molecule, conventional  replication was first
documented in 1968 by electron microscopy (10). Subsequent
to this, a novel mechanism of DNA replication was proposed
based on further electron microscopy and end mapping (11–
14). This strand displacement model envisaged a single unidi-
rectional origin for synthesis of the leading (heavy) strand (OH),
which proceeds approximately two-thirds of the way around
the genome until the lagging (light) strand origin (OL) is
exposed on the displaced parental heavy strand. In this model
the two strands are synthesized asynchronously and strand-
continuously, obviating the need for Okazaki fragments.
The validity of thismodel has recently been questioned based
on findings from two-dimensional agarose gel electrophoresis
(AGE), ligation-mediated PCRandnascent strand analysis (15–
20). These studies revealed evidence for fully duplex  replica-
tion intermediates indicative of strand-coupled replication.
However, many intermediates had extensive segments of RNA
incorporated throughout the lagging strand (denotedRITOLS).
The location of the replication origin also appeared to vary with
some initiation events occurring bidirectionally at positions
other than OH but with OH acting as a replication terminus.
Molecular recombination initiated by double strand breaks is
now recognized as a universal and indispensable adjunct to
DNA replication. It permits DNA replication to recover from
fork collapse (21). Stalled replication forks regress to formHol-
liday junction structures both inmammalian cells (22) and bac-
teria (23–25). These are then processed to restart replication
via the action of junctional resolvases and other components of
the recombinationmachinery (25–28). Recombination can also
initiate DNA replication in some systems, notably bacterio-
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phages such as T4 (29). In addition,molecular recombination is
a widespread, if not universal, mechanism of DNA repair nota-
bly of double strand breaks and involving exchange of material
between homologous segments of damaged and undamaged
DNA (30–32). Failures in this system in nuclear DNA are the
cause of a diverse spectrum of human diseases (33).
Plants, fungi, and some other organisms have been shown to
have active mtDNA recombination (for a review, see Ref. 34),
and genetic recombination has been reported in culturedmam-
malian cells harboring different mtDNA deletions or point
mutations (35, 36). Intramolecular recombination has also been
detected in mammalian cells containing partially duplicated
mtDNAs (37, 38). In the plant kingdom, a mitochondrial
homologue of the RecA protein has been found in both Ara-
bidopsis (39) and Physcomitrella (40). Recombination activ-
ity has been detected in lysates of mammalian mitochondria
(41), and abundant branched molecules having the character-
istics of a Holliday (four-way, X-) junction have been observed
in human cardiac muscle mtDNA by two-dimensional AGE
(42). Molecular structures resembling four-way junctions have
also been inferred in the vicinity of OH in mtDNA from cul-
tured mammalian cells and have been interpreted as pretermi-
nation intermediates (15, 43).
In the present work we addressed further the nature and
significance of the junctional molecules in human heart
mtDNA using a combination of one- and two-dimensional
AGE, transmission electronmicroscopy (TEM), and enzymatic
treatments. The results indicate that human heart as well as, to
a lesser extent, human and mouse brain, maintain mtDNA in
multigenomic complexes linked by intercatenation plus four-
way and three-way junctions. Standard -type replication inter-
mediates were not detectable in human heart mtDNA, indicat-
ing thatmtDNA replication proceeds via a non-mechanism in
this tissue. Lastly the pattern of mtDNA replication intermedi-
ates detected in the tissue of mice transgenic for either of two
proteins involved inmtDNAmaintenance,mitochondrial tran-
scription factor A (TFAM) and Twinkle, shows a substantial
increase in junctional forms.
EXPERIMENTAL PROCEDURES
DNA Extraction and Autopsy Series—Total DNA from cul-
tured cells was extracted by standard methods (43) and from
frozen forensic autopsy samples as described inHyvärinen et al.
(44). For full details see the supplemental data. The samples
were taken as part of theTampereCoronary Study, approved by
the Ethics Committee of Tampere University Hospital (DNO
1239/32/200/01) and the National Authority for Medico-legal
Affairs, and included cardiac muscle samples from 12 individ-
uals of different ages (for full details see Table 1). None had any
known history of heart disease. Pig and rabbit heart DNAswere
extracted similarly.
mtDNA Extraction—mtDNA was isolated from cultured
cells as described by Yasukawa et al. (19) and from human and
mouse tissues essentially as described by Reyes et al. (18) and
Yasukawa et al. (19): for full details see the supplemental data.
Tissue samples were frommice transgenic for Twinkle (Ref. 45,
line A) and TFAM (44) as well as non-transgenic littermate
controls.
Two-dimensional AGE—1 g of total mitochondrial
nucleic acids or 10 g (heart and brain) or 20 g (skeletal
muscle, kidney, and cultured cells) of total DNAwas used per
analysis. Restriction digestions and other enzyme treatments
were performed following the manufacturers’ recommenda-
tions (see Ref. 43 for enzyme details and suppliers). If subse-
quent treatment with another nuclease was used, DNA was
first recovered by ethanol precipitation and resuspended in
the appropriate reaction buffer before treatment with the
second enzyme. Reactions were stopped by the addition of
an equal volume of phenol-chloroform-isoamyl alcohol (25:
24:1, pH 8.0) and immediately extracted. Two-dimensional
AGE and Southern blotting were performed as described
previously (Ref. 43: note the different gel conditions for dif-
ferent fragment sizes).
One-dimensional AGE—1–5 g of total DNA or 100 ng of
mtDNA were used in the analysis. Subsequent treatments with
topoisomerase IV (John Innes Enterprises), topoisomerase I, T7
endonuclease I, or -exonuclease (all New England Biolabs)
used themanufacturers’ recommended conditions.Whenmul-
tiple enzyme treatments were used, DNA was ethanol-precipi-
tated between the steps. The gel conditions and blottingwere as
described in Pohjoismäki et al. (43).
Radiolabeled Probes and Blot Hybridization—For Southern
hybridization, probes were created by Pfu PCR using as tem-
plate cloned segments of human mtDNA (see Refs. 19, 44, and
45) or 18 S rDNA (primers, CTACTTGGAAAACTGTGGTA-
ATTCTA and TTTTAACTGCAGCAACTTTAATATAC,
both 5 to 3; i.e. nucleotides 24–772 of the human 18 S rDNA
sequence, NCBI accession number M10098). Mouse mtDNA
probes created frommousemtDNAby Pfu PCR followed by gel
purification spanned nucleotides 15357–136 (non-coding
region (NCR)) and 5383–5910 (COXI). Pig and rabbit probes
were created similarly from total DNA and correspond to the
mtDNA fragments ND1 (nucleotides 2821–3422) and COXI
(nucleotides 2551–2980), respectively. Probes were labeled
using a RediprimeTM II random prime labeling kit (Amersham
Biosciences) and [-32P]dCTP (Amersham Biosciences; 3000
Ci/mmol).
Transmission Electron Microscopy—Approximately 1 g of
nucleic acids extracted from sucrose density gradient-purified
TABLE 1
Details of human heart DNA samples used for analysis
F, female; M, male.
Sex Age Cause of death Type of analysis
yr
F 2 Foreign object in larynx Two-dimensional AGE of total DNA
M 19 Crush injury to skull Two-dimensional AGE of total DNA
F 22 Fatal wound Two-dimensional AGE of total DNA
M 23 Suicide by shotgun Two-dimensional AGE of total DNA
M 26 Car accident (suicide) TEM and two-dimensional AGE of
mtDNA
F 31 Drowning Two-dimensional AGE of total DNA
M 33 Drowning Two-dimensional AGE of total DNA
M 44 Hypothermia Two-dimensional AGE of total DNA
M 52 Car accident Two-dimensional AGE of total DNA
M 53 Suicide by handgun Two-dimensional AGE of total DNA
M 58 Gunshot wound to head
(homicide)
TEM and two-dimensional AGE of
mtDNA
F 69 Pneumonia TEM and two-dimensional AGE of
mtDNA
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human heart mitochondria was treated with 50 units of RNase
If (New England Biolabs) at 37 °C for 30 min in the manufac-
turer’s buffer, recovered by phenol-chloroform extraction and
ethanol precipitation, and redissolved in TEM grade TE buffer
(10 mM Tris-HCl, 0.1 mM ETDA, pH 7.6). A separate aliquot
was digested further with BamHI or PvuII and recovered simi-
larly. Aliquots (0.5–1.0 ng) of
mtDNA were prepared and directly
mounted on parlodion-coated grids
following the Kleinschmidt proce-
dure (46, 47). Imaging and image




ates Differ between Tissues—We set
out initially to characterize the
forms of mtDNA and its replication
intermediates present in different
human tissues. We digested post-
mortem DNA samples from human
heart and other tissues as well as
cultured (HEK293T) cells with each
of two restriction enzymes cutting
only once in the mitochondrial
genome but in different regions,
namely PvuII and BamHI (Fig. 1a).
Upon two-dimensional AGE,  rep-
lication intermediates, forming
bubble and double Y arcs plus the
eyebrow arc associated with
RITOLS-type replication (see sup-
plemental Fig. 1), were readily
detected in mtDNA of cultured
cells, brain, and kidney but were
very faint in skeletal muscle. A
standard initiation (bubble) arc was
seen in the PvuII digest (Fig. 1a,
panels ii–v). In the BamHI digest
(Fig. 1a, panels vii–x), a double Y arc
was prominent as well as either a
short bubble arc (in brain) or an
“eyebrow” arc resulting from non-
digestion at the restriction site (see
supplemental Fig. 1 for a fuller
explanation).
Standard  replication intermedi-
ates were not detectable in human
cardiac muscle mtDNA (Fig. 1a,
panels i and vi). The major mtDNA
replication intermediates (mtRIs)
were Y-formmolecules encompass-
ing the whole genome; the products
of the two digests were virtually
indistinguishable electrophoreti-
cally. A prominent (X) arc of puta-
tive recombination intermediates
(i.e.molecules containing four-way junctions) was also seen as
well as linear molecules migrating at 2n3 and complex forms
3 1n in the context used here means the unit length of the mitochondrial
genome, 16,569 base pairs of DNA. 2n thus means twice that, i.e. a mole-
cule of 33 kbp.
FIGURE 1. Two-dimensional AGE analysis of mtRIs from human tissues and cultured cells as indicated,
treated with restriction enzymes cutting once in the mitochondrial genome. a, mtDNA was linearized with
PvuII or BamHI as shown and hybridized with combined ND4 and OH region probes. The various arcs, inter-
preted in the panels below, represent dimeric linear molecules (2n), monomeric (c) and dimeric circles (2nc), Y
intermediates (Y), double Y intermediates (dY), replication bubbles (b), i.e. standard initiation arc, X forms (X; i.e.
dimeric fragments joined by four-way junctions), complex forms proposed to consist of multimeric fragments
joined by multiple four-way junctions (dX), and  molecules with broken arms attached to an intact circle (e;
forming an eyebrow arc). For fuller explanation of the gels, see supplemental Fig. 1. Note that only bubble and
double Y arcs can be considered as products of standard  replication in such analyses, although RITOLS-type
 replication can also generate eyebrow arcs (Yasukawa et al. (20)). b, two-dimensional AGE of PvuII-digested
mtDNA extracted from HEK 293T cells with or without 72 h of treatment with 100 M ddC to induce widespread
and prolonged replication stalling. Steady-state replication intermediates were greatly increased (panels i and
iii are similar exposures as are panels ii and v), but the predominant forms were still  bubbles and double Y
forms with only a minority of molecules suffering fork regression or nicking to generate broken bubbles (bb). sk,
skeletal.
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migrating at 2n in the first dimension that may represent
multimericmolecules held together bymore than one four-way
junction (denoted as dX in Fig. 1a).
To investigate whether the absence of the initiation arc in
heart could be explained as a trivial artifact arising from loss of
bubble structures during extraction, i.e. due to single strand
breakage at replication forks, we treated heart and HEK 293T
cell PvuII digests with single strand-specific nuclease S1 (sup-
plemental Fig. 2). The HEK 293T cell bubble arc was indeed
partially converted to a Y-like (broken bubble) arc, although its
trajectory was slightly different from that of the standard Y arc
seen in the heart sample, and the largest bubbles were relatively
resistant. Importantly S1 nuclease also preferentially degraded
theX arc and the 2n linearmolecules in the heart sample. These
observations indicate that the absence of standard  intermedi-
ates in heart mtDNA is not a degradation artifact. The mtRIs
revealed in human brain (Fig. 1a, panels ii and vii) resembled a
mixture of those from heart and from other tissues or cultured
cells.
In previous experiments we found that, in material prepared
from crudemitochondria,mtRIswere relatively degraded com-
pared with material extracted from sucrose gradient-purified
mitochondria; this was largely attributable to RNase H activity
(15). Because of the paucity of material and ethical consider-
ations, the human autopsy samples were generally prepared as
total DNA. We therefore conducted one experiment using
DNA extracted from sucrose density gradient-purified mito-
chondria of human cardiac muscle and cerebral cortex isolated
as soon as possible after death (6 h). Two-dimensional AGE
analysis of this material following
PvuII digestion (supplemental Fig.
3a) gave essentially indistinguish-
able results from those seen with
total DNA except that the brain
sample was less degraded with both
bubble and especiallyX forms better
preserved.
Two-dimensional AGE of sub-
genomic restriction fragments of
mtDNA confirmed consistent tis-
sue differences in the patterns of
mtRIs seen in heart compared with
other tissues or with cultured cells
(Fig. 2). We analyzed two overlap-
ping fragments of the genome,
namely the HincII fragment span-
ning the major NCR and containing
OH plus the overlapping DraI frag-
ment that excludes the NCR. The
mtRIs from sucrose density gradi-
ent-purified mitochondria of
cultured HEK 293T cells (Fig.
2b, panels vi and xii) included
the prominent RNA-containing
RITOLS intermediates as detected
previously, giving rise to slow mov-
ing Y-like arcs (denoted SMY). In
total DNA prepared from the same
cells (Fig. 2b, panels v and xi) these intermediates were, as pre-
viously (16), subject to partial degradation during extraction
because of RNase H activity, giving rise to modified slow mov-
ing Y-like arcs (mSMY). The latter were also seen in total DNA
from kidney (Fig. 2b, panels iv and x) and very faintly in total
DNA from skeletal muscle (Fig. 2b, panels iii and ix) where all
mtRIs were at low abundance. However, theywere not detected
in total DNA from heart (Fig. 2b, panels i and vii) or brain (Fig.
2b, panels ii and viii).
In both heart and brain samples standard Y and prominent X
arcs were seen in the DraI digest as well as high molecular
weight structures. In the HincII digest, initiation arcs were not
seen in the samples from heart or brain even on long exposure
(supplemental Fig. 3e), although initiation arcs (modified by
ribonucleotide loss) were visible at long exposure in total DNA
from cultured cells; supplemental Fig. 3d). However, the Y arc
was incomplete, suggesting that OH is still acting, even in heart,
as an obligatory terminus of replication. The abundant X arcs
seen in human cardiac muscle were not seen in equivalent
digests of total DNA from similarly processed cardiacmuscle of
othermammals (mouse, rabbit, and pig), whereas conventional
 replication intermediates of the RITOLS type were clearly
seen in these samples (supplemental Fig. 3b). Note that rabbit
and pig hearts were processed at least 24 h after death yet X arcs
were absent, indicating that they did not arise in the human
samples as a result of a post-mortem artifact under hypoxic
conditions In humans, X arcs were seen in cardiacmuscle DNA
from each of 15 different individuals irrespective of age (e.g.
supplemental Fig. 3c). Prominent X arcs were absent from all
FIGURE 2. Two-dimensional AGE analysis of mtRIs in different human tissues and cultured HEK 293T
cells, as indicated, using restriction enzymes cutting at multiple sites in the mitochondrial genome.
a, schematic map of human mtDNA showing the locations of relevant restriction sites and probes (asterisks).
The major NCR is shown as a dark gray bar, and rDNA is shown as a light gray bar. b, two-dimensional AGE blots,
digests, and probes as shown. All DNA samples were total DNA except panels vi and xii, which used mtDNA
extracted from sucrose gradient-purified mitochondria. The various arcs indicated (for clarity, and where obvi-
ous, not shown in every panel) represent X forms (X), Y intermediates (Y), putative double X forms (dX), “slow
moving” Y arcs (SMY) created by non-digestion at restriction sites blocked by RNA or single strandedness,
modified SMY arcs (mSMY) resulting from RNase H degradation, and termination intermediates (t) in which two
oppositely moving forks are juxtaposed. For a fuller explanation of the gels, see supplemental Fig. 1. Bubble
arcs, although not seen clearly at this exposure, were present in long exposures of panels iii–vi and ix–xii (e.g.
see supplemental Fig. 3e). sk, skeletal.
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digests and fragments of human cultured cell, kidney, and skel-
etal muscle mtDNA.
To exclude the possibility that theX arcs seen in humanheart
might arise as an artifact of preparation due to the regression of
stalled replication forks, we treated cultured cells for 72 h with
dideoxycytidine to induce systematic chain termination and
fork arrest in replicating mtDNA. As expected, this treatment
resulted in a large increase in the
steady-state level of mtRIs (Fig. 1b).
However,  forms were well pre-
served, and species migrating on
two-dimensional gels as X-junc-
tional molecules such as those seen
in myocardial mtDNA preparations
did not arise (Fig. 1b).
Human Heart mtDNA Is Orga-
nized in Multimeric Junctional
Complexes—The absence of stand-
ard  replication mtRIs in human
cardiac muscle prompted us to look
at the overall organization of
mtDNA in this tissue. We used
TEM to analyze human cardiac
muscle mtDNA prepared from
sucrose density gradient-purified
mitochondria (Fig. 3, a–c). The
absence of nuclear DNA contami-
nation was confirmed by Southern
blotting to an 18 S rDNAprobe (Fig.
3d). In contrast to mtDNA in cul-
tured HEK 293T cells, where the
majority of molecules were mono-
meric circles, most heart mtDNA
was organized in multimeric com-
plexes (Table 2 and Fig. 3). Some of
these, containing a substantial frac-
tion of the total mtDNAmass, were
complex tangles (e.g. Fig. 3a) con-
taining one or several nexuses and
frequently more than 20 genome
equivalents. At higher magnifica-
tion (e.g. Fig. 3b) the nexuses did not
appear to contain electron-dense
fibrousmaterial, such as that seen in
preparations of chromatin loops
associated with fragments of
nuclear matrix. They persisted after
digestion with proteinase K and fur-
ther phenol extraction. However,
the tangles were impossible to
parse. The simplest multimeric
arrays, containing just two to three
copies of the genome, appeared to
be held together by junctions (Fig.
3c), although their exact nature can-
not be inferred from TEM alone.
Tailed monomeric (or dimeric) cir-
cles were not seen, providing fur-
ther evidence that theY arcs seen on two-dimensional gelswere
not created by breakage of  bubbles. Conversely three-way
junctions that could give rise to the Y arcs seen on two-dimen-
sional gels were visible in the complex tangles mostly at or near
nexuses (Fig. 3b). The complex tangles were seen in different
spreads of the same mtDNA preparation and in mtDNA prep-
arations from three different individuals although not in HEK
FIGURE 3. TEM of human heart mtDNA. Scale bars, 200 nm. a, tangled complex of monomeric and dimeric
circles containing 20 genome equivalents. Some other tangled networks appeared even more complex.
b, nexuses of five different tangles at higher magnification. c, panel i, three monomeric circles held together by
junctions (arrows) (catenation, hemicatenation, and/or four-way recombination junctions). Panels ii–viii, exam-
ples of such junctions at higher magnification. Panels ii and iii are from the same complex as shown in panel i.
Panels iv–vi are from other paired circular molecules. Panels vii and viii are similar junctions seen in the multim-
eric tangles. d, Southern blot of purified mtDNA (1 g of nucleic acid) alongside total DNA (20 g) undigested
(U) or digested with PvuII (P) or EcoRI (E; E2 is an independent mtDNA sample from a second individual) and
either stained with ethidium bromide (EtBr) or blot-hybridized with probes for 18 S rDNA (18S) or cytochrome
b (cyt b; Ref. 19).
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293T cell mtDNA spread in parallel, making it highly unlikely
that they were created as an artifact of incomplete spreading.
They remained uncut by BglII, which has no recognition site in
human mtDNA but which cuts frequently in nuclear DNA.
Cerebral cortex mtDNA (not shown) was a mixture of the
forms seen in heart and in cultured cells, consistent with find-
ings from two-dimensional AGE.
We studied the topology of
human heart mtDNA further using
a combination of one- and two-di-
mensional AGE combined with var-
ious enzymatic treatments. The
most complex tangles could not be
resolved electrophoretically (Fig. 4).
Material unable to enter the first
dimension gel was completely lost
when one-dimensional gels were
processed for blotting (Fig. 4a) but
was retained in two-dimensional
gels (material denoted tgl in Fig. 4b).
Most of the material that did enter
one-dimensional gels migrated as
two broad bands (Fig. 4a) denoted t
and f. Only a small proportion of the
material migrated as monomeric
supercoils, in contrast to mtDNA
from cultured HEK 293T cells elec-
trophoresed under identical condi-
tions (41). This accords with the
findings fromTEM.A small amount
ofmonomeric (1n) and dimeric (2n)
linear mtDNA was detected (Fig. 4,
a and b, panel i).
The tangles were efficiently
converted to simpler, electro-
phoretically interpretable forms
by combined treatment with
topoisomerase IV, a decatenating
enzyme that also removes super-
coils, and phage T7 endonuclease I,
which cuts cruciform junctions. Neither enzyme alone resolved
the tangles, although treatment with T7 endonuclease I alone
did allow some of the high molecular weight material to enter
the first dimension gel. The tangles are therefore inferred to be
held together by a combination of catenation and four-way
junctions. The limit products from combined treatment with
the two resolving enzymesweremonomeric and dimeric circles
and linear molecules as well as a large quantity of heterogene-
ous linear DNA ranging in size from 2n to 1n. Trimeric or
higher order linear molecules (or circles) were absent and were
not generated by any enzymatic treatment.
Two-dimensional AGE and enzymatic digestion revealed
that bands t and f were each composed of several different spe-
cies. The more retarded portion of band t was modified by
topoisomerase IV but not by topoisomerase I or by T7 endonu-
clease I, indicating that it consisted of catenated dimers ormul-
timers. One novel species was generated by topoisomerase IV
treatment (denoted x in Fig. 4b, panel ii) that migrated in the
same part of the first dimension gel (band f) as monomeric
circles and dimeric linear molecules but was more retarded
than either of the latter forms in the second dimension. This
species as well as being released by decatenation was sensitive
to both T7 endonuclease I and -exonuclease (Fig. 4a), identi-
fying it as a circle joined to a linear molecule by a four-way
junction. The remainingmaterial of band twas resistant to all of
FIGURE 3—continued
TABLE 2
Representation of different molecular forms in mtDNA from human
heart and cultured HEK 293T cells analyzed by electron microscopy
RI, replication intermediate.
mtDNA source na 1n circles 2n circles Pairsb Complexesc RIs
HEK 293T cells 1005 853 2 73 22 52
Heart 500 178 167 88 61d 6e
a Total number of molecular species assigned.
b Two circular molecules linked by tight catenation or recombination junctions (e.g.
Fig. 3c). This class excludes molecules that appeared as two overlapping circles in
the spread (which were excluded completely from the analysis because such fig-
ures are ambiguous).
c Aggregates of three ormoremolecules linked by tight catenation or recombination
junctions. In general, such complexes visualized in HEK 293T cell mtDNA com-
prised just three to fivemolecules (e.g. supplemental Fig. 4), whereas those in heart
frequently contained 20 molecules in highly tangled complexes (Fig. 3, a and b).
d Because most of these complexes contained 20 molecules they represented a
substantial fraction of the total mass of mtDNA in heart, perhaps 50% or more.
e No  intermediates were seen in heart. The six molecules scored as “replication
intermediates” were all aberrant structures, such as those illustrated in supple-
mental Fig. 4b, containing junctions and linear ends and of less than one genome
length equivalent in total. They may be assumed to have broken off from the
tangled complexes.
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the enzymatic treatments tested
and migrated as dimeric open cir-
cles, a species also seen abundantly
by TEM (Table 2). The above find-
ings indicate that most mtDNA in
human heart is organized in junc-
tional complexes held together by
catenation and four-way junctions.
The effects of topoisomerase IV
were verified by TEM (Fig. 4, c and
d). The complex tangles were
greatly simplified, releasing a com-
bination of decatenatedmonomeric
and dimeric circles as well as per-
sisting junctional forms. These
included many examples of circular
molecules still joined together by
what are most simply interpreted as
four-way junctions (Fig. 4c) as well
as other molecules containing
three-way junctions, linear ends,
and/or linear segments apparently
joining circles to linear molecules
(e.g. Fig. 4d) or to other circles.
To investigate the relationship
between these junctional forms and
mtDNA replication, we digested
heart mtDNA with PvuII or BamHI
prior to spreading for TEM (Fig. 5).
In addition to simple linear mole-
cules, we saw many molecules still
linked by junctions. Some material
remained in loosely tangled net-
works, which could not be parsed
reliably. Interpretable junctions
were of three types: four-way junc-
tions usually with at least two
branches of equal length (Fig. 5,
a–d), three-way junctions with
branches of equal (Fig. 5e) or
unequal length (Fig. 5f), and com-
plex junctions (Fig. 5, g–i). Many
four-way junctions appeared to
comprise two closely spaced junc-
tions joined by a short bridge of
intertwined duplex or partially
resected material equivalent to the
classic double Holliday junction
intermediate of the double strand
break repair model of homologous
recombination (49). Complex (mul-
tiple) junctions were found at the
nexuses of persistent tangles as well
as in simpler molecules (Fig. 5, g–i).
Apart from a few classic Y-form
molecules (e.g. Fig. 5e), which could
arise by a variety of mechanisms,
the non-linear mtDNA species
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observed after digestion were inconsistent with standard  rep-
lication, and molecular species predicted to arise from  inter-
mediates were absent. Conversely the junctional forms seen in
heart were not seen in material from cultured cells processed
identically.
Junctional mtDNA Molecules Are Enhanced in Tissues of
TFAM and Twinkle Transgenic Mice—We noted that the tis-
sues in which junctional mtDNA species were prominent were
also those exhibiting highest mtDNA copy number (supple-
mental Table 1). To investigate further the relationship
between mtDNA copy and organization, we analyzed mtDNA
in two transgenic mouse models in which overexpression of
proteins involved inmtDNAmetabolism results in a copy num-
ber increase, i.e. the mitochondrial DNA helicase Twinkle (43)
and human TFAM (44, 48).
We used two-dimensional AGE to compare mtRIs in differ-
ent tissues of TFAM and Twinkle transgenic mice of different
ages and in non-transgenic littermates (Fig. 6). mtRIs were
detectable only at relatively low levels in control heart (Fig. 6, b
and c, panels i; d, panel ii; and e, panel iii) but were consistently
enhanced and altered by Twinkle overexpression (Fig. 6, b and
c, panels ii; d, panel iii; and e, panel iv) regardless of age,
whereas those in liver were indistinguishable from controlmice
(Fig. 6, b and c, panels iv and v; and e, panels i and ii). The
changes in heart represented a shift toward forms resembling
those seen in human heart, i.e. the appearance of X arcs (puta-
tive recombination intermediates containing four-way junc-
tions) in all regions of the genome tested. Initiation (bubble)
arcs, indicative of standard  replication, persisted as did the
arcs attributable to RITOLS intermediates. TFAM overexpres-
sion produced a similar but more dramatic effect in heart (Fig.
6, b and c, panels iii) with the appearance of prominent X arcs
accompanied by relative loss of initiation arcs and of RITOLS
intermediates plus a slight induction of X arcs in liver (panels
vi). In brain, X arcs were present alongside standard  replica-
tion intermediates even in control mice, but Twinkle overex-
pression resulted in a large increase thereof (Fig. 6, e, panels i
and ii; and f, panels v and vi). Twinkle overexpression also pro-
duced a small increase in X-junctional forms in skeletal muscle,
whereas they were only visible in control mouse muscle at long
exposure (supplemental Fig. 4, panels iii and iv).
One-dimensional agarose gel electrophoresis (Fig. 7) also
confirmed the appearance of complex junctional forms in
Twinkle- (Fig. 7, a and b) or TFAM-overexpressing (Fig. 7c)
heart but not liver. Like those in human heart (Fig. 4), these
were resolved by topoisomerase IV and T7 endonuclease I
(Fig. 7b).
DISCUSSION
This study combines two major, primary findings on human
heart mtDNA: the absence of standard  replication intermedi-
ates and its organization in junctional complexes that have
some similarities withmtDNAnetworks reported previously in
plants (8). The fact that these observations were made in the
same tissue raises the issue of whether and how they are related.
In both cases we have excluded the obvious artifactual explana-
tions (nuclear DNA contamination, freeze-thaw or post-mor-
tem damage, branch migration, or fork regression during
extraction).Note that the unusual formswere absent from sam-
ples of mouse, pig, or rabbit heart processed in a similar
manner.
The absence of standard  replication intermediates com-
bined with the abundant presence of molecules containing
three-way, four-way, and more complex junctions implies
strongly that human heart mtDNA must replicate by a non-
mechanism.  intermediates were not released by resolving
enzymes (restriction or junctional endonucleases or topoi-
somerases). Nor did we observe any credible examples of repli-
cation bubbles inside the junctional complexes. However, the
unresolved networks are so complex thatwe cannot exclude the
possibility that junctions are systematically branch-migrated
and resolved as replication forks advance. Nevertheless this
would clearly not be standard  replication.
The Relationship betweenmtDNAOrganization andReplica-
tion in Human Heart—Analysis of junctional complexes by
resolving enzymes, electrophoresis, and TEMdoes not allow us
to extrapolate a specific alternative replication model at this
time. All we can infer is that the intermediates predicted by any
previously proposed mtDNA replication model are absent,
implying that a novel type of replication is occurring. Note that
although standard  forms were absent so were the structures
predicted by the strand asynchronous replication model (14):
human heart mtDNA forms containing four-way junctions are
largely resistant to S1 nuclease (Ref. 42; see also supplemental
Fig. 1). We also cannot completely exclude that the unusual
structures seen are, at least in part, a manifestation of mtDNA
repair processes. However, this would not explain the absence
of standard replication intermediates. Conversely the presence
of four-way junctions does not imply that recombination, as
classically understood, is taking place because these structures
could equally well be generated during DNA replication. The
forms detected are not those of conventional rolling circle or
recombination-dependent replication as seen, respectively, in
yeast mtDNA (4, 50) or in bacteriophage T4 (29), chloroplast
FIGURE 4. Electrophoretic and TEM analysis of human heart mtDNA. a, one-dimensional AGE of undigested cardiac muscle mtDNA treated with the
enzymes as indicated (topoisomerase (Topo) I, topoisomerase IV, T7 endonuclease (endo) I, and -exonuclease (exo)). The identity of the various species is
inferred by the effects of enzymatic treatments on their relative amounts and by their migration properties on two-dimensional AGE (b). Bands t and f are each
composites of several species. -Exonuclease digests molecules with exposed 5 phosphorylated ends. Because it removes or modifies the residual material
running just behind open circles after topoisomerase IV treatment, i.e. 2n linear molecules plus species x (b, panel ii), we infer that species x has exposed ends.
b, two-dimensional AGE of cardiac muscle mtDNA untreated (panel i), treated with topoisomerase IV (panel ii), treated with T7 endonuclease I (panel iii), and
treated with topoisomerase IV  T7 endonuclease I (panel iv). The topology of the various forms, annotated on the gel images and inferred from the treatments
and electrophoretic mobilities, is shown below the gel panels. tgl, tangled complexes (see Fig. 3); cat, catenanes (can also include 2 monomeric or dimeric
circles); 1n and 2n, monomeric and dimeric linear molecules, respectively; c and 2nc, monomeric and dimeric open circles, respectively; sc and 2nsc, supercoiled
monomeric and dimeric circles, respectively. xc, circular molecules joined by four-way junctions; x, suggested to be circles joined to linear molecules by
four-way junctions. Arrows indicate directions of first and second dimension electrophoresis. c and d, examples of forms seen by TEM following topoisomerase
IV treatment of heart mtDNA alongside interpretations. Distinct circles and linear segments are indicated in different colors with inferred contour lengths in kb
or (for circles) genome lengths. Scale bars, 200 nm.
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(51), and some plant mitochondrial DNAs (52–55). However,
replication forks (three-way junctions) were clearly present
within the junctional complexes and persisted in the residual
material after treatment with restriction or resolving enzymes.
This indicates that DNA replication actually takes place within
the junctional networks, thus giving it features of both rolling
circle and recombination-dependent replication with the T4
phage system probably the closest precedent. The absence of
FIGURE 5. TEM of PvuII- and BamHI-digested human cardiac muscle mtDNA. a–i, images of various junctional molecules alongside interpretations are
shown. In each case except f at least two branches (plus two other branches if entirely within the field) are of equal length. Note that many junctions appear to
be composite, i.e. to consist of two adjacent four-way (and/or three-way) junctions. Distinct linear segments emanating from junctions are indicated in different
colors with inferred contour lengths in kb. Scale bars, 200 nm.
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replicating monomers implies that
heart mtDNA does not replicate in
the same way as the catenated
mtDNA networks of kinetoplastids
(56). Resolution of these issues will
require the development and valida-
tion of a satisfactory model system,
e.g. based on metabolic labeling in
organ explants or differentiating
stem cells in vitro, as well as the
identification and functional
characterization of the proteins
involved.
Tissue and Species Differences in
mtDNA Organization and Repli-
cation—In mtDNA from cultured
human cells and most tissues,
standard  replication intermedi-
ates were easily detected both by
TEM and two-dimensional AGE
(see also Ref. 19), whereas junc-
tional networks appeared to be
absent. In human brain, however,
we observed both standard  inter-
mediates and junctional com-
plexes as if material from heart
and cultured cells was simply
mixed together. One simple expla-
nation for this observation would
be that brain, which contains
many different cell types, may sim-
ply be heterogeneous with regard
to mtDNA organization and repli-
cation with some heartlike cell
types and other cells of the stand-
ard type in this respect. Alterna-
tively the two modes of mtDNA
organization and replication may
co-exist in the same cells. The issue
will not be easily resolved because
both TEM and two-dimensional
AGE require significant amounts of
purified material that cannot easily
be obtained by microdissection.
Circular dimers and catenanes
of mtDNA were observed previ-
ously in leukemic leukocytes and
other cell lines (57, 58). However,
in vivo tissues were not studied,
and the forms observed were gen-
erally much less complex than we
report here for human heart.
Moreover no evidence of four-way
junctions was found. It is an
intriguing although unlikely possi-
bility that, in granulocytic leuke-
mias, mtDNA replication in some
way mimics human heart.
FIGURE 6. Two-dimensional AGE analysis of mtRIs in Twinkle and TFAM transgenic mice and non-
transgenic controls. a, summary map of mouse mtDNA (nomenclature as in Fig. 2) showing relevant
probes and restriction fragments. b, MluI-linearized mtDNA from 10-month-old Twinkle transgenic mice,
non-transgenic littermate controls, and 8-week-old TFAM transgenic mice with tissues and probe as
indicated. The various arcs represent monomeric circles (c), X forms (X), replication bubbles (b), double Y
(dY) intermediates, and forms proposed to comprise three or more fragments joined by four-way junc-
tions (dX). For clarity, and where obvious, these are not indicated in each individual gel panel. In the TFAM
mouse samples an additional arc is seen running below the trajectory of the standard initiation arc, which
probably arose by degradation of lagging strand RNA during shipment of the samples. c, DraI-digested
mtDNA probed for the 4.5-kb COXI-containing fragment; mice, tissues, and arcs are indicated as in b. Y,
standard Y arcs; SMY, slow moving Y-like arcs arising from restriction site blockage due to lagging strand
RNA (Yang et al. (16)). d, similar DraI digests from 6-week-old mice. The mtDNA alterations in hearts of
transgenic Twinkle mice are seen already in young animals. e, ClaI-digested mtDNA probed for the 4.3-kb
NCR-containing fragment; mice, tissues, and arcs are indicated as in a– e. Note that a double Y arc is seen
in non-transgenic heart DNA where it probably corresponds with termination intermediates. A much
more prominent X arc is evident in Twinkle transgenic mice in both heart and brain (and also control
brain), but this arc may not extend to the double-stranded DNA linear arc except in the case of Twinkle-
transgenic mouse brain, suggesting that junction formation in this fragment occurs preferentially in the
center of the fragment near the OH-distal boundary of the NCR.
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In other mammals we found an extraordinary difference
from humans, namely that heartmtDNAorganization and rep-
lication appeared to be of the standard  type. In the mouse,
frequent four-way junctions were found only in brain mtDNA.
However, we were able to induce the formation of junctions in
mouse heart mtDNA by transgenic overexpression of two dif-
ferent proteins implicated in mtDNA transactions, both of
which also provoked an increase in mtDNA copy number (45,
59, 60). There is a rough correlation between copy number and
the formation of junctional complexes. In humans, heart has
the highestmtDNAcopy number of any tissue studied based on
our own (supplemental Table 1) as well as published measure-
ments (61–63). However, monomeric organization is clearly
not incompatiblewith high copy number in the case of bacterial
plasmids.
In the two transgenic overexpression models we studied,
TFAM had a stronger effect on both mtDNA organization and
copy number than Twinkle. However, effects on mtDNA orga-
nization may be independent of those on copy number: TFAM
is known to bind preferentially to four-way junctions (64), and
its homologues in both bacteria (HU) and yeast mitochondria
bind similarly and facilitate recombination (65–69). The viral
homologue of Twinkle, the bacteriophage T7 gene 4 protein,
can also catalyze directly a strand transfer reaction in the pres-
ence of the phage-encoded single-strand binding protein (70).
Another possibility is that the species differences are related
only to developmental timing, i.e. reflecting a programmed
developmental switch from standard to junctional mtDNA
organization in human heart possibly connected also with
aging. All human cardiac samples to which we had access were
far older in years than the maximum mouse lifespan even if
some were relatively young considered as a fraction of total
human lifespan. However, there are many physiological differ-
ences between human and mouse heart (e.g. work load, beat
rate, and reserve capacity) that could underlie the difference.
Functional Significance of Junctional mtDNA Organiza-
tion—Even if they reflect high mtDNA copy number, the func-
tional significance of junctional mtDNA networks inferred to
be replicating by a non- mechanism is unclear. We offer two
hypotheses, which future experiments inmodel systemsmay be
able to address.
A high frequency of somatic recombination in a multicopy
genome can be considered as one means of suppressing the
sequence variation arising by somatic mutation. In effect, this
provides a copy correctionmechanismoperating in tissueswith
a highmetabolic rate and thusmost susceptible to reactive oxy-
gen species-induced mtDNA damage. The mouse TFAM and
Twinkle models offer a potential way to test this hypothesis.
Alternatively in tissues where such damage is inevitable, an
mtDNA organization that keeps variant molecules physically
linked may minimize segregation and thus maximize comple-
mentation. Intriguingly TFAM overexpression in mouse heart
also confers resistance to the damaging effects of ischemic
stress (59).
Another explanation for junctional organization would be
that it facilitates high level gene expression. Although four-way
junctions present a theoretical barrier to transcription, efficient
branch migration and resolution may mitigate this problem. A
junctional network may facilitate recycling of transcriptional
complexes in a manner analogous with the transcriptional fac-
tories of the nucleolus. This may be of special importance in
tissues where intracellular organization dictates that the bio-
genesis of new oxidative phosphorylation complexes should be
spatially concentrated or restricted, e.g. in neuronal synapses or
in the highly organized myofibrils of heart muscle.
This study constitutes the first report of tissue-specific dif-
ferences in mtDNA organization and replication in mammals.
Given the enormous tissue variability in the manifestations of
mitochondrial disease in humans, a full understanding of this
phenomenon is likely to havemajor implications formitochon-
drial pathophysiology.
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